Sisters homozygous for the spinocerebellar ataxia type 6 (SCA6)/CACNA1A gene associated with different clinical phenotypes

被引:29
|
作者
Kato, T
Tanaka, F
Yamamoto, M
Yosida, E
Indo, T
Watanabe, H
Yoshiwara, T
Doyu, M
Sobue, G
机构
[1] Nagoya Univ, Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Kasugai Municipal Hosp, Dept Neurol, Kasugai, Aichi, Japan
关键词
CAG repeat; gene dosage effect; homozygotes; phenotypic expression; spinocerebellar ataxia type 6;
D O I
10.1034/j.1399-0004.2000.580112.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Spinocerebellar ataxia type 6 (SCA6) is a neurodegenerative disease caused by a CAG repeat expansion in the CACNA1A gene. The neurodegeneration that occurs in CAG repeat diseases is considered to share a common mechanism that may result in the gain of a toxic function related to the expanded polyglutamine tracts. However, the phenotypic expression in homozygotes for CAG repeat diseases has been controversial, and is not clearly related to a gain of functional mechanism. We identified a Japanese family with two sisters who were homozygous for the SCA6 with identical CAG repeat expansion (25/ 25). They showed an earlier age of onset (27 years in both) than their father (44 years), a heterozygote with an expanded allele showing the same CAG repeat length as the homozygotes (25/14). Interestingly, the two sisters showed differences in disease progression and severity, although the age of onset and CAG repeat length were identical. These findings strongly suggest that the gene dosage influences the age of onset, but other unknown factors are also important in the phenotypic expression of homozygous SCA6.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 50 条
  • [1] Meiotic instability of the CAG repeats in the SCA6/CACNA1A gene in two Japanese SCA6 families
    Shimazaki, H
    Takiyama, Y
    Sakoe, K
    Amaike, M
    Nagaki, H
    Namekawa, M
    Sasaki, H
    Nakano, I
    Nishizawa, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 185 (02) : 101 - 107
  • [2] Spinocerebellar ataxia type 6 (SCA6): Clinical pilot trial with gabapentin
    Nakamura, Katsuya
    Yoshida, Kunihiro
    Miyazaki, Daigo
    Morita, Hiroshi
    Ikeda, Shu-ichi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 278 (1-2) : 107 - 111
  • [3] Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6)
    Khan, NL
    Giunti, P
    Sweeney, MG
    Scherfler, C
    Brien, MO
    Piccini, P
    Wood, NW
    Lees, AJ
    MOVEMENT DISORDERS, 2005, 20 (09) : 1115 - 1119
  • [4] Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p
    Jodice, C
    Mantuano, E
    Veneziano, L
    Trettel, F
    Sabbadini, G
    Calandriello, L
    Francia, A
    Spadaro, M
    Pierelli, F
    Salvi, F
    Ophoff, RA
    Frants, RR
    Frontali, M
    HUMAN MOLECULAR GENETICS, 1997, 6 (11) : 1973 - 1978
  • [5] Molecular physiopathology of the spinocerebellar ataxia type 6 (SCA6)
    Cervantes-Kardasch, VH
    García-Martínez, E
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2004, 56 (03): : 368 - 374
  • [6] Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6)
    Hidenao Sasaki
    Hideaki Kojima
    Ichiro Yabe
    Kunio Tashiro
    Takeshi Hamada
    Hirofumi Sawa
    Hiroaki Hiraga
    K. Nagashima
    Acta Neuropathologica, 1998, 95 : 199 - 204
  • [7] Predisposing chromosome for spinocerebellar ataxia type 6 (SCA6) in Japanese
    Yabe, I
    Sasaki, H
    Yamashita, I
    Tashiro, K
    Takei, A
    Suzuki, Y
    Kida, H
    Takiyama, Y
    Nishizawa, M
    Hokezu, Y
    Nagamatsu, K
    Oda, T
    Ohnishi, A
    Inoue, I
    Hata, A
    JOURNAL OF MEDICAL GENETICS, 2001, 38 (05) : 328 - 333
  • [8] The cerebellum and cognitionIntellectual function in spinocerebellar ataxia type 6 (SCA6)
    C. Globas
    S. Bösch
    Ch. Zühlke
    I. Daum
    J. Dichgans
    K. Bürk
    Journal of Neurology, 2003, 250 : 1482 - 1487
  • [9] Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6)
    Sasaki, H
    Kojima, H
    Yabe, I
    Tashiro, K
    Hamada, T
    Sawa, H
    Hiraga, H
    Nagashima, K
    ACTA NEUROPATHOLOGICA, 1998, 95 (02) : 199 - 204
  • [10] Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6
    Parviz Daniel Hejazi Pastor
    Xiaofei Du
    Sarah Fazal
    Andre N. Davies
    Christopher M. Gomez
    The Cerebellum, 2018, 17 : 72 - 77